LINZESS is celebrating 10 years of helping patients with IBS-C and CIC1
LINZESS® (linaclotide) is indicated in adults for the treatment of both irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).1
Please see Important Safety Information below.
Please see link for full Prescribing Information above for additional information.
US-LIN-220238